Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016. [electronic resource]
- Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis Dec 2018
- 227-233 p. digital
Publication Type: Journal Article
1744-2818
10.1080/13506129.2018.1536043 doi
Aged Aged, 80 and over Antineoplastic Agents--therapeutic use Biomarkers--analysis Bortezomib--therapeutic use Cohort Studies Female Follow-Up Studies Hematologic Tests Humans Immunoglobulin Light-chain Amyloidosis--diagnosis Male Middle Aged Prognosis Survival Rate